http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003003487-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2323-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1274
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
filingDate 2000-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9e2e9f19405f475baa4e02d826e00e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1d5ed03a72f409c036bb82a69d73f2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5699861a48de9b23e9c63261ea121039
publicationDate 2003-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2003003487-A1
titleOfInvention Mixed structures resulting from the incorporation of a biological macromolecule, especially of dna, in a liquid crystal phase of amphiphiles, and vesicles obtained using these structures
abstract The invention relates to a structured mixed phase formed by the incorporation of a biological macromolecule into a liquid-crystal phase of amphiphiles, preferably a lamellar phase, wherein said biological macromolecule is present in said structured mixed phase in an amount of at least 5% by weight, based on the amphiphilic compounds constituting said liquid-crystal phase of amphiphiles, and wherein at least one of the two entities consisting of the biological macromolecules, on the one hand, and all the amphiphilic compounds, on the other, is of an uncharged nature. n The biological macromolecules incorporated into the structured mixed phases of the invention are preferably selected from polynucleotides, particularly DNA or RNA, proteins and polysaccharides. n The invention further relates to vesicles obtained by dispersion of the above structured mixed phases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113560595-A
priorityDate 1999-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6387396-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5679355-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226524490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18631913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226551309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129491332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226551310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128745802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136221892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12303145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129645792

Total number of triples: 43.